United Immunity, Co.
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $11M
Investors
- 6
About United Immunity, Co.
, Ltd. specializes in innovative drug delivery systems, merging immunotherapy with nanoparticle technology to enhance therapeutic efficacy in treating various diseases, including cancer and autoimmune disorders., Ltd. focuses on developing advanced drug delivery systems. Naozumi Harada is the founder, with a history of involvement in the biotechnology sector., Ltd. specializes in the development of innovative drug delivery systems that integrate immunotherapy and nanoparticle technology. Core products like Pullulan Nanoparticles (PNP) and Pullulan-Lipid Nanoparticles (P-LNP) are engineered to selectively deliver therapeutic agents to myeloid cells to enhance treatments for diseases such as cancer and autoimmune disorders.The revenue model of United Immunity is based on partnerships with pharmaceutical and biotech companies to develop and commercialize proprietary drug delivery systems. Through B2B transactions, the company generates revenue via licensing agreements and collaborations, involving milestone payments and royalties based on the success of the drugs delivered using their Myeloid Targeting Platform™., Ltd. It also received?from new Japan Agency for Medical Research and Development. The company plans to use the September 2026 funds to accelerate the clinical development of UI-102 and its in vivo immunotherapy programs.
Who invested in United Immunity, Co.
6 investors across 3 rounds
See all investors in United Immunity, Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about United Immunity, Co.
Who invested in United Immunity, Co.?
United Immunity, Co. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has United Immunity, Co. raised?
United Immunity, Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did United Immunity, Co. last raise money?
United Immunity, Co.'s most recent round on record is a Series B, in Sep 2023.
What does United Immunity, Co. do?
United Immunity, Co. is a healthcare specialists company.
Where is United Immunity, Co. headquartered?
United Immunity, Co. is headquartered in Tokyo, Japan.
Which VCs invest in companies like United Immunity, Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at United Immunity, Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like United Immunity, Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.